Improved
6121 HealthChanged
3792 LivesSaved
3577 Lives0 lives impacted in the last 24 hrs Learn More
A recent New England Journal of Medicine article reported on the results of the ARISTOTLE trial comparing the effectiveness of apixaban and warfarin for atrial fibrillation stroke prevention. Apixaban was shown to be superior to warfarin in preventing afib strokes. Learn more about the results of this trial at:
Apixaban Superior to Warfarin for Atrial Fibrillation Stroke Prevention
The FDA has just announced expedited review of Eliquis for atrial fibrillation stroke prevention, with approval expected by March 28, 2012.
All user-generated information on this site is the opinion of its author only and is not a substitute for medical advice or treatment for any medical conditions. Members and guests are responsible for their own posts and the potential consequences of those posts detailed in our Terms of Service.
Add a Comment1 Comments
Thank you for sharing this latest development with the EmpowHer community. It is valuable information for anyone with atrial fibrillation.
November 30, 2011 - 5:02pmThis Comment